Ginkgo Bioworks continues to face a weak demand environment, which has contributed to a lack of growth in recent years. Learn ...

The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a decrease of 11.11% from the prior estimate of $12.24 dated November 7, 2025. The ...

Ginkgo Bioworks Holdings recently unveiled a collaboration with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign. This partnership marks a new chapter in the company’s ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

Ginkgo Bioworks Holdings reported its Q3 2025 earnings, highlighting a significant drop in revenue and a decrease in cash burn. Despite innovative strides in lab automation and AI applications, the ...

Ginkgo Bioworks recently announced a five-year partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign, funded by ARPA-H, to develop new phage-based ...

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It ...

(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable prior ...

BOSTON, Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year ...

Includes $0.3 million and $0.2 million in employer payroll taxes for the three months ended September 30, 2025 and 2024, respectively, and $0.9 million and $2.9 million for the nine months ended ...

Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium).